Stay updated on Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added to the page footer, and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.
    Difference
    0.1%
    Check dated 2025-12-23T21:41:00.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2; this is a minor version change and does not affect study content or user actions—To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:33:07.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    A banner states that due to a lapse in government funding, the information on the site may be out of date and transactions may be delayed; it also notes the NIH Clinical Center is open and directs readers to opm.gov for status updates.
    Difference
    0.4%
    Check dated 2025-11-18T07:16:39.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    No significant changes detected in core study details, eligibility criteria, or primary outcomes; any updates appear to be minor formatting or layout adjustments that do not affect the information presented. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:24:14.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    4%
    Check dated 2025-10-06T06:38:09.000Z thumbnail image
  9. Check
    101 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:13:35.000Z thumbnail image

Stay in the know with updates to Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial page.